Cargando…
Alendronate Use and Risk of Type 2 Diabetes: A Nationwide Danish Nested Case-Control Study
OBJECTIVE: A link has been proposed between glucose homeostasis and bone metabolism. Bisphosphonates are first-line treatment of osteoporosis, and we aimed to investigate whether the risk of developing type 2 diabetes was associated with prior use of alendronate. RESEARCH DESIGN AND METHODS: We cond...
Autores principales: | Viggers, Rikke, Al-Mashhadi, Zheer, Starup-Linde, Jakob, Vestergaard, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640922/ https://www.ncbi.nlm.nih.gov/pubmed/34867816 http://dx.doi.org/10.3389/fendo.2021.771426 |
Ejemplares similares
-
The Efficacy of Alendronate Versus Denosumab on Major Osteoporotic Fracture Risk in Elderly Patients With Diabetes Mellitus: A Danish Retrospective Cohort Study
por: Viggers, Rikke, et al.
Publicado: (2022) -
The risk of major osteoporotic fractures with GLP-1 receptor agonists when compared to DPP-4 inhibitors: A Danish nationwide cohort study
por: Al-Mashhadi, Zheer Kejlberg, et al.
Publicado: (2022) -
SGLT2 inhibitor treatment is not associated with an increased risk of osteoporotic fractures when compared to GLP-1 receptor agonists: A nationwide cohort study
por: Al-Mashhadi, Zheer Kejlberg, et al.
Publicado: (2022) -
Associations of Circulating Osteoglycin With Bone Parameters and Metabolic Markers in Patients With Diabetes
por: Starup-Linde, Jakob Kau, et al.
Publicado: (2021) -
Associations with fracture in patients with diabetes: a nested case–control study
por: Starup-Linde, Jakob, et al.
Publicado: (2016)